APA (7th ed.) Citation

Strunz, P., Schmalzing, M., Heidemeier, A., Rasche, L., Einsele, H., & Kortüm, K. M. (2019). Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor. Leukemia & Lymphoma, 60(14), 3573. https://doi.org/10.1080/10428194.2019.1636981

Chicago Style (17th ed.) Citation

Strunz, Patrick-Pascal, Marc Schmalzing, Anke Heidemeier, Leo Rasche, Hermann Einsele, and K. Martin Kortüm. "Response to Daratumumab in Rituximab-resistant EBV-associated PTLD Following Allogenic Stem Cell Transplantation from an EBV Seronegative Donor." Leukemia & Lymphoma 60, no. 14 (2019): 3573. https://doi.org/10.1080/10428194.2019.1636981.

MLA (9th ed.) Citation

Strunz, Patrick-Pascal, et al. "Response to Daratumumab in Rituximab-resistant EBV-associated PTLD Following Allogenic Stem Cell Transplantation from an EBV Seronegative Donor." Leukemia & Lymphoma, vol. 60, no. 14, 2019, p. 3573, https://doi.org/10.1080/10428194.2019.1636981.